A judge has questioned a challenge by two class actions against Victorian aged care providers to a ruling that rejected their bid for insurance and financial information, which the defendants argue would have far-reaching implications.
Two cosmetic surgeons have filed defamation suits seeking aggravated damages over coverage by the ABC and Fairfax that allegedly painted them as âoutlaw surgeonsâ who mutilated a patient and exploited the Medicare system.
Monash Health has won its challenge to a decision finding it wrongfully dismissed a librarian in a âshamâ redundancy.
An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause âdisablingâ side effects, including nerve damage and psychosis.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
Monash IVF is gearing up for a legal privilege fight as it faces new claims about the team of senior doctors and directors working on a novel testing technique at the heart of a class action, including claims that one doctor âburnt paper evidenceâ from a trial of the technology.
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns about Amgen having a majority of experts giving concurrent evidence. In an application filed at the beginning of the month, the French pharmaceutical company sought to bar Amgen from relying…
A former top judge appointed to decide the first-ever contest to administer a class action settlement has set out his criteria for making the choice, and has warned that giving the firm running a case a monopoly right to dole out the proceeds could lead to higher costs for group members and poorer settlement outcomes.
The first healthcare provider to be found liable in one of several underpayments class actions by junior doctors is challenging a ruling that found permission to work overtime hours did not have to be expressly given.
Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.